1. Associate Professor of comparative effectiveness and outcomes research, School of Pharmacy, University of Connecticut, Storrs, CT, USA2. Researcher, Vicerrectorado de Investigacion (VRI), Universidad San Ignacio de Loyola (USIL), Lima, Peru
M.D., Ph.D., FACC, FESC
Physician trained in clinical epidemiology and cardiovascular research, with extensive experience (18+ years) in design, analysis, reporting, publication and supervision of observational studies and randomized controlled trials. Also, extensive experience (15+ years) in design, development and evaluation of clinical research protocols. Advanced statistical and methodological knowledge and experience including regression, predictive modeling, meta-analysis, and clinical practice guidelines. As of today, Dr. Hernandez has 206 peer-reviewed publications in Pubmed.Currently focused on comparative effectiveness and outcomes research, development of clinical practice guidelines, and systematic reviews and meta-analyses of cohort studies and randomized trials, with special attention to drug and device safety. Previous experience in prognostic modeling and subgroup analyses of randomized controlled trials.Topics of interest and expertise in clinical research are cardiovascular diseases (acute coronary syndromes, heart failure, atrial fibrillation, diabetes, obesity, vascular/cardiac surgery), novel oral anticoagulants, peri-operative medicine, obstructive sleep apnea, and HIV-associated infections.
Universidad Nacional Mayor de San Marcos, Lima, Peru (1990-1998), including rotatory internship of 1 year.
San Fernando Medical School, Universidad Nacional Mayor de San Marcos, and HIV/AIDS Unit, First Service of Internal Medicine, Hospital General Universitario Guillermo Almenara Irigoyen, both in Lima, Peru.
Faculty of Science and Philosophy, Universidad Peruana Cayetano Heredia, Lima, Peru
Netherlands Institute for Health Sciences (NIHES), Erasmus Medical Centre, Rotterdam, TheNetherlands.
Departments of Public Health and Cardiology, Erasmus Medical Centre, Rotterdam, The Netherlands. Topic: Heterogeneity of patients in randomized clinical trials.
Department of Cardiology, Cardiovasculaire Onderzoek Erasmus Universiteit Rotterdam (COEUR), Erasmus Medical Centre, Rotterdam, The Netherlands.
Systematic reviews and meta-analyses, including network meta-analysis, especially those evaluating rare events and adverse/harmful events of drugs and devices. Clinical applications in cardiovascular medicine, infectious diseases and perioperative medicine.
Development and validation of prognostic models, especially the modeling of time-dependent covariates and competing risk analysis. Clinical applications in cardiovascular medicine, infectious diseases, and nephrology/urology.
De-novo development, adaptation and adoption of clinical practice guidelines in a broad range of clinical topics including hemophilia, chronic back pain, treatment for chronic hepatitis C infection, acute coronary syndrome, heart failure, and cardiac transplantation.
In case of any questions, please contact the ILEP Secretary – Patrycja Lewandowicz: